Merck Mercuriadis In The News

Why the ’80/20 rule’ will be crucial to Hipgnosis’ mission to buy billions of dollars of music catalogs in 2022 and beyond

Hipgnosis has over $2.5 billion of deals in the pipeline. The question of who's going to pay for them requires a complex but important answer.

Hipgnosis Songs Fund share price hits all-time high on London Stock Exchange

Merck Mercuriadis' company is worth 22.87% more than it was when it hit the stock exchange in 2018

From Spotify vs. songwriters to Adele vs. our emotions: It’s MBW’s Weekly Round-up

The biggest stories of the past five days – and why they matter

Interviews News

What do Blackstone’s billions mean for Merck Mercuriadis’ mission for songwriters?

The Hipgnosis founder joins Blackstone's Qasim Abbas in MBW's in-depth interview RE: the deal everyone's talking about

Official: Blackstone is investing $1 billion in music rights via Merck Mercuriadis and Hipgnosis… and there could be billions more on the way.

Blackstone tells MBW "this is just the start" and that its ambition in music is "much more substantial"

Here. Come. The. Giants.

Blackstone x Hipgnosis; KKR; Apollo Global Management. They're all in.

Merck Mercuriadis: ‘None of us should be able to sleep in good conscience at night until the true value of the songwriters’ contributions to this business are recognized.’

Merck Mercuriadis responds to criticism of his views regarding the major record companies and publishers

Hipgnosis buys catalog from Fleetwood Mac’s Christine McVie

Catalog includes 11 No.1s and 47 Top 10s